Phenytoin toxicity: Difference between revisions

(Text replacement - "==Treatment==" to "==Management==")
(Text replacement - "==Diagnosis==" to "==Evaluation==")
Line 27: Line 27:
==Differential Diagnosis==
==Differential Diagnosis==


==Diagnosis==
==Evaluation==
{{Phenytoin toxicity level chart}}
{{Phenytoin toxicity level chart}}



Revision as of 12:03, 24 July 2016

Background

  • Mortality is extremely rare after intentional overdose if good supportive care is provided
  • Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form --> myocardia depression & cardiac arrest)
  • 90% protein bound; dialysis ineffective

Clinical Features

  • CV (only with IV form)
  • Neuro
    • Nystagmus
      • First only with forced lateral gaze; later becomes spontaneous
      • May disappear at higher levels
    • Ataxia
    • Decreased LOC
  • GI
  • Skin
    • tissue infiltration (IV) --> "purple glove syndrome"
    • edema, pain, ischemia, tissue necrosis, compartment syndrome
  • Anticonvulsant hypersensitivity syndrome

Differential Diagnosis

Evaluation

Toxicity symptoms by phenytoin level^

Level Sypmtoms
>10 Usually no symptoms
10-20 Occasional mild nystagmus
20-30 Nystagmus
30-40 Ataxia, slurred speech, Nausea/vomiting
40-50 Lethargy, confusion
>50 Coma, seizure (rare)

^Provides a rough guide only; neither sensitive nor specific

Management

Disposition

  • Cannot base on phenytoin level (erratic absorption after PO overdose)
    • Consider discharge if patient has only mild symptoms and serial phenytoin levels decline

See Also

References